NEW Uscom Newsletter issued 12/03/2020, page-18

Elzephyrus - Re my posting: "Uscom News for Investors".
True - not a lot of new Info for those that are well read and keep a close watch on UCM affairs. However there is a great deal to see if you know the background. You may have missed bits like: ...
"These Chinese Guidelines are beginning implementation nowand Uscom is now selling devices for special application in COVID-19 applications with the first into the Shandong Provincial Chest Hospital, Chongqing Public Health and Medical Centre and Jintiang First People’s Hospital. There are a number of outstanding Chinese Government tenders currently in process for Hospitals requiring advanced Haemodynamic Monitoring".

"The recent government and academic supporting recommendations for USCOM 1A are changing our business as the requirement for high quality cardiovascular and pulmonary devices to provide precision care for large numbers of patients world wide becomes recognised.Uscom is responding by growing distributors, increasing manufacturing and developing additional clinical support and training strategies to support the increased demand.
These transformational recommendations include:1. Chinese Government Recommend USCOM 1A for Treatment of Severe Coronavirus Cases.
2. International SCCM Recommendations for Global Pediatric Sepsis Guidelines."

The Newsletter to shareholder investors issued by the Company (while not a price sensitive ASX announcement) tells you in quite clear terms that: - - the COVID-19 threat has propelled the USCOM devices to the forefront of equipment of use to meet this challenge;
- It tells you Uscom 1A is the only instrument in its class in the world;
- it tells you that this has been internationally recognised;
- that the Uscom 1A has been officially adopted in China - as the Standard of Care;
- that the 1A is now International SCCM Recommendations for Global Pediatric Sepsis Guidelines.(treatment of Corona virus in children);
- Chinese Government tenders are currently in process;
- some prominent Chinese institutions have already taken delivery and are making full use of the benefits;
- that there are many more sales in the pipeline in China and now other countries
- that the company is already focused on the major structural changes needed to meet this challenge.

So the newsletter actually clarifies and confirms a very great deal that is of fundamental importance to company progress.
Once again this highlights just how forward thinking and well organised UCM - there is little doubt in my mind they will rise to the challenge.
Given that UCM were so close to cashflow positive - I think it is not hard to guess this is now a given and growing!

I am sorry you had trouble reading the original newsletter post - I have since learned a bit and will try and do a better job next time.